Overview

Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/s

Status:
Withdrawn

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

The objective of this phase III study is to evaluate the efficacy, systemic safety and local tolerability of P-3073 (calcipotriene 0.005%) nail solution in patients with mild to moderate psoriatic fingernail/s.

Phase:

Phase 3

Details

Lead Sponsor:

Almirall, S.A.
Polichem S.A.

Collaborator:

Almirall, S.A.

Treatments:

Calcipotriene
Calcitriol